tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nathan Treybeck, 22 are a BUY (55%), 18 are a HOLD (45%).
Analyst Nathan Treybeck, currently employed at WELLS FARGO, carries an average stock price target met ratio of 64.81% that have a potential upside of 15.84% achieved within 99 days.
Nathan Treybeck’s has documented 80 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 08-Jul-2026.
Analyst best performing recommendations are on NVRO (NEVRO CORP).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 8/7/2024. The price target of $5.5 was fulfilled within 1 day with a profit of $0.67 (13.87%) receiving and performance score of 138.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Aug-2023
$160
$42.83 (36.55%)
$170
18 days ago
(16-Jul-2026)
11/17 (64.71%)
$44.65 (38.71%)
177
Buy Since 06-Apr-2026
$150
$32.83 (28.02%)
$160
28 days ago
(06-Jul-2026)
2/6 (33.33%)
$23.97 (19.02%)
34
Buy Since 21-Jan-2021
$185
$67.83 (57.89%)
$185
1 months 12 days ago
(22-Jun-2026)
10/15 (66.67%)
$80.31 (76.71%)
574
Buy Since 22-Aug-2024
$157
$39.83 (33.99%)
$214
2 months 30 days ago
(04-May-2026)
24/29 (82.76%)
$37.82 (31.73%)
205
Buy Since 13-Jan-2026
$180
$62.83 (53.62%)
$200
3 months 2 days ago
(01-May-2026)
5/8 (62.5%)
$59.2 (49.01%)
308
Which stock is Nathan Treybeck is most bullish on?
Which stock is Nathan Treybeck is most reserved on?
What Year was the first public recommendation made by Nathan Treybeck?
